Evidence map›Paper›PMID 30949030›Full record

ReviewFrontiers in cellular neuroscience2019

The Complex Work of Proteases and Secretases in Wallerian Degeneration: Beyond Neuregulin-1.

Marta Pellegatta, Carla Taveggia

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. ADAM17 Regulates p75The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  11. Peripheral Nerve Injury Treatments and Advances: One Health Perspective.International journal of molecular sciences · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. NADNature reviews. Molecular cell biology · 2021
    Review
  18. Peripheral Nerve Regeneration and Muscle Reinnervation.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marta PellegattaDivision of Neuroscience and INSPE at IRCCS San Raffaele Scientific Institute, Milan, Italy.
Carla TaveggiaDivision of Neuroscience and INSPE at IRCCS San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University · IT

Funding

MOLECULAR MECHANISMS CONTROLLING PNS MYELIN MAINTENANCER01NS099102 · NINDS · SAN RAFFAELE HOSPITAL · PI TAVEGGIA, CARLA · 2018 to 2022
$1.3M
NINDS NIH HHS R01 NS099102
6 · The paper itself

Abstract

After damage, axons in the peripheral nervous system (PNS) regenerate and regrow following a process termed Wallerian degeneration, but the regenerative process is often incomplete and usually the system does not reach full recovery. Key steps to the creation of a permissive environment for axonal regrowth are the trans-differentiation of Schwann cells and the remodeling of the extracellular matrix (ECM). In this review article, we will discuss how proteases and secretases promote effective regeneration and remyelination. We will detail how they control neuregulin-1 (NRG-1) activity at the post-translational level, as the concerted action of alpha, beta and gamma secretases cooperates to balance activating and inhibitory signals necessary for physiological myelination and remyelination. In addition, we will discuss the role of other proteases in nerve repair, among which A Disintegrin And Metalloproteinases (ADAMs) and gamma-secretases substrates. Moreover, we will present how matrix metalloproteinases (MMPs) and proteases of the blood coagulation cascade participate in forming newly synthetized myelin and in regulating axonal regeneration. Overall, we will highlight how a deeper comprehension of secretases and proteases mechanism of action in Wallerian degeneration might be useful to develop new therapies with the potential of readily and efficiently improve the regenerative process.

Indexed as

fibrinolysismatrix metalloproteinasesremyelinationsecretaseswallerian degeneration

Identifiers

PMID30949030
PMCPMC6436609
OpenAlexW2924314733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.